Outcomes Of Patients (Pts) Treated With Prior Blinatumomab (Blin) In Zuma-3: A Study Of Kte-C19, An Anti-Cd19 Chimeric Antigen Receptor (Car) T Cell Therapy, In Adult Pts With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R All).
JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要